Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Objectives The frontline drug doxorubicin has been used for treating cancer for over 30 years. While providing a cure in select cases, doxorubicin causes toxicity to most major organs, especially life-threatening cardiotoxicity, which forces the treatment to become dose-limiting. Key findings Doxoru...
| Main Authors: | , , |
|---|---|
| Format: | Journal Article |
| Published: |
John Wiley & Sons Ltd.
2013
|
| Online Access: | http://hdl.handle.net/20.500.11937/19817 |